Recruiting NA Stroke

New treatment option for Stroke

Official title Error-enhanced Learning & Recovery in 2 & 3 Dimensions

ClinicalTrials.gov ID: NCT05180786

What this study is testing

What it's testing
This study is being done to see how errors lead to improvement. Specifically, we are evaluating the errors stroke participants make during an upper extremity exercise program when reaching for a target using their affected arm.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older. Healthy volunteers may be eligible.

You may be able to join if

  • 18 years of age or older
  • Chronic stroke (8+ months post stroke event) with primary motor cortex involvement
  • Hemiparesis
  • Some degree of both shoulder and elbow movement capability

You likely can't join if

  • Bilateral paresis
  • Severe tactile deficits using the Two-Point Discrimination Test (participant must detect\<11mm)
  • Severe proprioceptive deficits
  • Severe spasticity (Modified Ashworth \>3) preventing movement
  • Aphasia, cognitive impairment, or affective dysfunction that would influence the ability to perform the experiment
  • Visual deficits, and hemispatial neglect that would prevent the people from seeing the targets.
See the full eligibility criteria
Who can join
  • 18 years of age or older
  • Chronic stroke (8+ months post stroke event) with primary motor cortex involvement
  • Hemiparesis
  • Some degree of both shoulder and elbow movement capability
What rules you out
  • Bilateral paresis
  • Severe tactile deficits using the Two-Point Discrimination Test (participant must detect\<11mm)
  • Severe proprioceptive deficits
  • Severe spasticity (Modified Ashworth \>3) preventing movement
  • Aphasia, cognitive impairment, or affective dysfunction that would influence the ability to perform the experiment
  • Visual deficits, and hemispatial neglect that would prevent the people from seeing the targets.
  • Inability to provide an informed consent
  • severe current medical problems
  • diffuse/multiple lesion sites or multiple stroke events
  • Inability to attain and maintain testing positions
  • Botox injection to the affected upper extremity within the previous 4 months
  • Concurrent participation in upper extremity rehabilitation either as part of a research intervention protocol or a prescribed therapy
  • Participation in previous, similar robotics intervention study
  • Other neurological issues None of the following special populations will be included in this research study:
  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners
  • Vulnerable Populations

The study team makes the final eligibility decision.

Where it's taking place

  • Chicago, Illinois, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.